EP1206559A2 - Inhibition conditionnelle de multiplication vegetative - Google Patents
Inhibition conditionnelle de multiplication vegetativeInfo
- Publication number
- EP1206559A2 EP1206559A2 EP00961249A EP00961249A EP1206559A2 EP 1206559 A2 EP1206559 A2 EP 1206559A2 EP 00961249 A EP00961249 A EP 00961249A EP 00961249 A EP00961249 A EP 00961249A EP 1206559 A2 EP1206559 A2 EP 1206559A2
- Authority
- EP
- European Patent Office
- Prior art keywords
- gene
- rooting
- inhibiting
- product
- codes
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 230000005764 inhibitory process Effects 0.000 title claims abstract description 31
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 126
- 230000002401 inhibitory effect Effects 0.000 claims abstract description 57
- 238000000034 method Methods 0.000 claims abstract description 27
- 238000005520 cutting process Methods 0.000 claims abstract description 25
- 239000000126 substance Substances 0.000 claims abstract description 24
- 230000014509 gene expression Effects 0.000 claims abstract description 23
- 230000001939 inductive effect Effects 0.000 claims abstract description 21
- 230000009261 transgenic effect Effects 0.000 claims abstract description 21
- 230000033228 biological regulation Effects 0.000 claims abstract description 18
- 230000000694 effects Effects 0.000 claims abstract description 18
- 238000004519 manufacturing process Methods 0.000 claims abstract description 8
- UQHKFADEQIVWID-UHFFFAOYSA-N cytokinin Natural products C1=NC=2C(NCC=C(CO)C)=NC=NC=2N1C1CC(O)C(CO)O1 UQHKFADEQIVWID-UHFFFAOYSA-N 0.000 claims description 33
- 239000004062 cytokinin Substances 0.000 claims description 33
- 230000015572 biosynthetic process Effects 0.000 claims description 29
- 101150012864 ipt gene Proteins 0.000 claims description 27
- 230000000692 anti-sense effect Effects 0.000 claims description 7
- 108090000790 Enzymes Proteins 0.000 claims description 5
- 102000004190 Enzymes Human genes 0.000 claims description 5
- 102100039556 Galectin-4 Human genes 0.000 claims description 4
- 101000608765 Homo sapiens Galectin-4 Proteins 0.000 claims description 4
- 238000012986 modification Methods 0.000 claims description 4
- 230000004048 modification Effects 0.000 claims description 4
- 239000012882 rooting medium Substances 0.000 claims description 4
- 230000005026 transcription initiation Effects 0.000 claims description 4
- 230000005030 transcription termination Effects 0.000 claims description 4
- 230000015556 catabolic process Effects 0.000 claims description 3
- 108010088245 cytokinin oxidase Proteins 0.000 claims description 3
- 238000006731 degradation reaction Methods 0.000 claims description 3
- 230000019491 signal transduction Effects 0.000 claims 2
- 230000007246 mechanism Effects 0.000 abstract description 8
- 241000196324 Embryophyta Species 0.000 description 34
- SEOVTRFCIGRIMH-UHFFFAOYSA-N indole-3-acetic acid Chemical compound C1=CC=C2C(CC(=O)O)=CNC2=C1 SEOVTRFCIGRIMH-UHFFFAOYSA-N 0.000 description 19
- 229930192334 Auxin Natural products 0.000 description 16
- 239000002363 auxin Substances 0.000 description 16
- HYVABZIGRDEKCD-UHFFFAOYSA-N N(6)-dimethylallyladenine Chemical compound CC(C)=CCNC1=NC=NC2=C1N=CN2 HYVABZIGRDEKCD-UHFFFAOYSA-N 0.000 description 14
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 14
- JTEDVYBZBROSJT-UHFFFAOYSA-N indole-3-butyric acid Chemical compound C1=CC=C2C(CCCC(=O)O)=CNC2=C1 JTEDVYBZBROSJT-UHFFFAOYSA-N 0.000 description 11
- 244000061176 Nicotiana tabacum Species 0.000 description 9
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 9
- 230000006698 induction Effects 0.000 description 9
- 230000000100 anti-cytokinin effect Effects 0.000 description 8
- 101150075111 ROLB gene Proteins 0.000 description 7
- 239000004202 carbamide Substances 0.000 description 7
- UZKQTCBAMSWPJD-UQCOIBPSSA-N trans-Zeatin Natural products OCC(/C)=C\CNC1=NC=NC2=C1N=CN2 UZKQTCBAMSWPJD-UQCOIBPSSA-N 0.000 description 6
- UZKQTCBAMSWPJD-FARCUNLSSA-N trans-zeatin Chemical compound OCC(/C)=C/CNC1=NC=NC2=C1N=CN2 UZKQTCBAMSWPJD-FARCUNLSSA-N 0.000 description 6
- 229940023877 zeatin Drugs 0.000 description 6
- 108020004414 DNA Proteins 0.000 description 5
- 238000000338 in vitro Methods 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- 102000053187 Glucuronidase Human genes 0.000 description 4
- 108010060309 Glucuronidase Proteins 0.000 description 4
- 206010052428 Wound Diseases 0.000 description 4
- 208000027418 Wounds and injury Diseases 0.000 description 4
- 238000011534 incubation Methods 0.000 description 4
- 239000002609 medium Substances 0.000 description 4
- YKOFIURKTHXXTH-UHFFFAOYSA-N n-cyclobutyl-2-methyl-7h-pyrrolo[2,3-d]pyrimidin-4-amine Chemical compound C=12C=CNC2=NC(C)=NC=1NC1CCC1 YKOFIURKTHXXTH-UHFFFAOYSA-N 0.000 description 4
- 239000000843 powder Substances 0.000 description 4
- -1 4-substituted 2-methylpyrrolo [2, 3-d]pyrimidines Chemical class 0.000 description 3
- CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical compound C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 description 3
- 239000005557 antagonist Substances 0.000 description 3
- HMFHBZSHGGEWLO-TXICZTDVSA-N beta-D-ribose Chemical group OC[C@H]1O[C@@H](O)[C@H](O)[C@@H]1O HMFHBZSHGGEWLO-TXICZTDVSA-N 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 238000013537 high throughput screening Methods 0.000 description 3
- 239000003617 indole-3-acetic acid Substances 0.000 description 3
- 239000003112 inhibitor Substances 0.000 description 3
- NUHSROFQTUXZQQ-UHFFFAOYSA-N isopentenyl diphosphate Chemical compound CC(=C)CCO[P@](O)(=O)OP(O)(O)=O NUHSROFQTUXZQQ-UHFFFAOYSA-N 0.000 description 3
- 239000002243 precursor Substances 0.000 description 3
- 230000000644 propagated effect Effects 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- KQRMGBSYWRUESQ-UHFFFAOYSA-N (2-chlorophenyl)sulfonylurea Chemical compound NC(=O)NS(=O)(=O)C1=CC=CC=C1Cl KQRMGBSYWRUESQ-UHFFFAOYSA-N 0.000 description 2
- FNQJDLTXOVEEFB-UHFFFAOYSA-N 1,2,3-benzothiadiazole Chemical compound C1=CC=C2SN=NC2=C1 FNQJDLTXOVEEFB-UHFFFAOYSA-N 0.000 description 2
- PRPINYUDVPFIRX-UHFFFAOYSA-N 1-naphthaleneacetic acid Chemical compound C1=CC=C2C(CC(=O)O)=CC=CC2=C1 PRPINYUDVPFIRX-UHFFFAOYSA-N 0.000 description 2
- RKMGAJGJIURJSJ-UHFFFAOYSA-N 2,2,6,6-Tetramethylpiperidine Substances CC1(C)CCCC(C)(C)N1 RKMGAJGJIURJSJ-UHFFFAOYSA-N 0.000 description 2
- UPJKSWLLCONYMW-UHFFFAOYSA-N 5'-Adenosine monophosphate Natural products COc1cc(O)c(C(=O)C)c(OC2OC(COC3OC(C)C(O)C(O)C3O)C(O)C(O)C2O)c1 UPJKSWLLCONYMW-UHFFFAOYSA-N 0.000 description 2
- HDZZVAMISRMYHH-UHFFFAOYSA-N 9beta-Ribofuranosyl-7-deazaadenin Natural products C1=CC=2C(N)=NC=NC=2N1C1OC(CO)C(O)C1O HDZZVAMISRMYHH-UHFFFAOYSA-N 0.000 description 2
- 239000005964 Acibenzolar-S-methyl Substances 0.000 description 2
- UDMBCSSLTHHNCD-UHFFFAOYSA-N Coenzym Q(11) Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(COP(O)(O)=O)C(O)C1O UDMBCSSLTHHNCD-UHFFFAOYSA-N 0.000 description 2
- JPVYNHNXODAKFH-UHFFFAOYSA-N Cu2+ Chemical compound [Cu+2] JPVYNHNXODAKFH-UHFFFAOYSA-N 0.000 description 2
- 240000006497 Dianthus caryophyllus Species 0.000 description 2
- 235000009355 Dianthus caryophyllus Nutrition 0.000 description 2
- 235000011430 Malus pumila Nutrition 0.000 description 2
- 235000015103 Malus silvestris Nutrition 0.000 description 2
- ANCLKUYYIJMBNK-UHFFFAOYSA-N OC(N(C(C=C1)=CC=C1Cl)OC1=CC=NC=C1)=O Chemical compound OC(N(C(C=C1)=CC=C1Cl)OC1=CC=NC=C1)=O ANCLKUYYIJMBNK-UHFFFAOYSA-N 0.000 description 2
- 239000005937 Tebufenozide Substances 0.000 description 2
- 239000004098 Tetracycline Substances 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- UDMBCSSLTHHNCD-KQYNXXCUSA-N adenosine 5'-monophosphate Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]1O UDMBCSSLTHHNCD-KQYNXXCUSA-N 0.000 description 2
- 108010050516 adenylate isopentenyltransferase Proteins 0.000 description 2
- 238000003556 assay Methods 0.000 description 2
- 230000000903 blocking effect Effects 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 229910001431 copper ion Inorganic materials 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 230000002068 genetic effect Effects 0.000 description 2
- 239000003862 glucocorticoid Substances 0.000 description 2
- 239000000411 inducer Substances 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- 150000002739 metals Chemical class 0.000 description 2
- PYSKLHFSEYWNDZ-UHFFFAOYSA-N n-cyclopentyl-2-methylsulfanyl-7h-pyrrolo[2,3-d]pyrimidin-4-amine Chemical compound C=12C=CNC2=NC(SC)=NC=1NC1CCCC1 PYSKLHFSEYWNDZ-UHFFFAOYSA-N 0.000 description 2
- 230000004983 pleiotropic effect Effects 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- QYPNKSZPJQQLRK-UHFFFAOYSA-N tebufenozide Chemical compound C1=CC(CC)=CC=C1C(=O)NN(C(C)(C)C)C(=O)C1=CC(C)=CC(C)=C1 QYPNKSZPJQQLRK-UHFFFAOYSA-N 0.000 description 2
- 229960002180 tetracycline Drugs 0.000 description 2
- 229930101283 tetracycline Natural products 0.000 description 2
- 235000019364 tetracycline Nutrition 0.000 description 2
- 150000003522 tetracyclines Chemical class 0.000 description 2
- 238000013519 translation Methods 0.000 description 2
- HDZZVAMISRMYHH-KCGFPETGSA-N tubercidin Chemical compound C1=CC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O HDZZVAMISRMYHH-KCGFPETGSA-N 0.000 description 2
- MVXCVJMJFMTFOR-UHFFFAOYSA-N (2-amino-2-phenylethyl) phosphono hydrogen phosphate Chemical compound OP(=O)(O)OP(O)(=O)OCC(N)C1=CC=CC=C1 MVXCVJMJFMTFOR-UHFFFAOYSA-N 0.000 description 1
- DBZQFUNLCALWDY-PNHWDRBUSA-N (2r,3r,4s,5r)-2-(4-aminoimidazo[4,5-c]pyridin-1-yl)-5-(hydroxymethyl)oxolane-3,4-diol Chemical compound C1=NC=2C(N)=NC=CC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O DBZQFUNLCALWDY-PNHWDRBUSA-N 0.000 description 1
- CKMCBMIMENXXFJ-NXBSNPICSA-N (2r,3s,5r)-5-(6-amino-6-anilino-8h-purin-9-yl)-2-(hydroxymethyl)oxolan-3-ol Chemical compound N1=CN=C2N([C@@H]3O[C@H](CO)[C@@H](O)C3)CN=C2C1(N)NC1=CC=CC=C1 CKMCBMIMENXXFJ-NXBSNPICSA-N 0.000 description 1
- FIDRAVVQGKNYQK-UHFFFAOYSA-N 1,2,3,4-tetrahydrotriazine Chemical compound C1NNNC=C1 FIDRAVVQGKNYQK-UHFFFAOYSA-N 0.000 description 1
- MBIZXFATKUQOOA-UHFFFAOYSA-N 1,3,4-thiadiazole Chemical compound C1=NN=CS1 MBIZXFATKUQOOA-UHFFFAOYSA-N 0.000 description 1
- FGIJPZDUXLSZJI-UHFFFAOYSA-N 1-(4-methoxyphenyl)-3-quinolin-8-ylurea Chemical compound C1=CC(OC)=CC=C1NC(=O)NC1=CC=CC2=CC=CN=C12 FGIJPZDUXLSZJI-UHFFFAOYSA-N 0.000 description 1
- YKMJOAVCSAOXOU-UHFFFAOYSA-N 2-phenyl-7h-purin-6-amine Chemical compound N=1C=2N=CNC=2C(N)=NC=1C1=CC=CC=C1 YKMJOAVCSAOXOU-UHFFFAOYSA-N 0.000 description 1
- AJOZCAUEINWEEG-UHFFFAOYSA-N 3,3,3-triphenylpropan-1-amine Chemical compound C=1C=CC=CC=1C(C=1C=CC=CC=1)(CCN)C1=CC=CC=C1 AJOZCAUEINWEEG-UHFFFAOYSA-N 0.000 description 1
- RUZQLRPRQPKGJL-UHFFFAOYSA-N 3-methyl-n-pentyl-2h-pyrazolo[4,3-d]pyrimidin-7-amine Chemical compound CCCCCNC1=NC=NC2=C(C)NN=C12 RUZQLRPRQPKGJL-UHFFFAOYSA-N 0.000 description 1
- PFCBHFDNVFQUJI-UHFFFAOYSA-N 3-methylbut-2-en-1-amine Chemical compound CC(C)=CCN PFCBHFDNVFQUJI-UHFFFAOYSA-N 0.000 description 1
- 125000004172 4-methoxyphenyl group Chemical group [H]C1=C([H])C(OC([H])([H])[H])=C([H])C([H])=C1* 0.000 description 1
- LQMSJZJWUAIFCW-UHFFFAOYSA-N 6-chloro-2-n-cyclobutyl-4-n-ethyl-1,3,5-triazine-2,4-diamine Chemical compound CCNC1=NC(Cl)=NC(NC2CCC2)=N1 LQMSJZJWUAIFCW-UHFFFAOYSA-N 0.000 description 1
- OAUKGFJQZRGECT-UUOKFMHZSA-N 8-Azaadenosine Chemical compound N1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OAUKGFJQZRGECT-UUOKFMHZSA-N 0.000 description 1
- VJUPMOPLUQHMLE-UUOKFMHZSA-N 8-Bromoadenosine Chemical compound BrC1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O VJUPMOPLUQHMLE-UUOKFMHZSA-N 0.000 description 1
- 108010085238 Actins Proteins 0.000 description 1
- 244000144730 Amygdalus persica Species 0.000 description 1
- 244000099147 Ananas comosus Species 0.000 description 1
- 235000007119 Ananas comosus Nutrition 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 241000167854 Bourreria succulenta Species 0.000 description 1
- NCDHALCXPBZELA-UHFFFAOYSA-N C(C1=CC=CC=C1)NC1=NC=C2N=CN(C2=N1)CCC(=O)O.COC1=CC=C(C=C1)NC(=O)NC1=CC=NC=C1 Chemical compound C(C1=CC=CC=C1)NC1=NC=C2N=CN(C2=N1)CCC(=O)O.COC1=CC=C(C=C1)NC(=O)NC1=CC=NC=C1 NCDHALCXPBZELA-UHFFFAOYSA-N 0.000 description 1
- 239000002126 C01EB10 - Adenosine Substances 0.000 description 1
- 240000004160 Capsicum annuum Species 0.000 description 1
- 235000008534 Capsicum annuum var annuum Nutrition 0.000 description 1
- 235000007516 Chrysanthemum Nutrition 0.000 description 1
- 240000005250 Chrysanthemum indicum Species 0.000 description 1
- 241000219112 Cucumis Species 0.000 description 1
- 235000015510 Cucumis melo subsp melo Nutrition 0.000 description 1
- 240000008067 Cucumis sativus Species 0.000 description 1
- 235000010799 Cucumis sativus var sativus Nutrition 0.000 description 1
- 102000016736 Cyclin Human genes 0.000 description 1
- 108050006400 Cyclin Proteins 0.000 description 1
- 238000002965 ELISA Methods 0.000 description 1
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 1
- 239000005977 Ethylene Substances 0.000 description 1
- 206010020649 Hyperkeratosis Diseases 0.000 description 1
- 235000007688 Lycopersicon esculentum Nutrition 0.000 description 1
- 240000008790 Musa x paradisiaca Species 0.000 description 1
- 235000018290 Musa x paradisiaca Nutrition 0.000 description 1
- NWBJYWHLCVSVIJ-UHFFFAOYSA-N N-benzyladenine Chemical compound N=1C=NC=2NC=NC=2C=1NCC1=CC=CC=C1 NWBJYWHLCVSVIJ-UHFFFAOYSA-N 0.000 description 1
- 238000000636 Northern blotting Methods 0.000 description 1
- 235000006040 Prunus persica var persica Nutrition 0.000 description 1
- 235000014443 Pyrus communis Nutrition 0.000 description 1
- 108010034634 Repressor Proteins Proteins 0.000 description 1
- 102000009661 Repressor Proteins Human genes 0.000 description 1
- 241000109329 Rosa xanthina Species 0.000 description 1
- 235000004789 Rosa xanthina Nutrition 0.000 description 1
- 240000000111 Saccharum officinarum Species 0.000 description 1
- 235000007201 Saccharum officinarum Nutrition 0.000 description 1
- 240000003768 Solanum lycopersicum Species 0.000 description 1
- 238000002105 Southern blotting Methods 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- FZWLAAWBMGSTSO-UHFFFAOYSA-N Thiazole Chemical compound C1=CSC=N1 FZWLAAWBMGSTSO-UHFFFAOYSA-N 0.000 description 1
- DNPIJKNXFSPNNY-UUOKFMHZSA-N [(2r,3s,4r,5r)-5-(6-amino-8-bromopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl dihydrogen phosphate Chemical compound BrC1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]1O DNPIJKNXFSPNNY-UUOKFMHZSA-N 0.000 description 1
- FJJCIZWZNKZHII-UHFFFAOYSA-N [4,6-bis(cyanoamino)-1,3,5-triazin-2-yl]cyanamide Chemical compound N#CNC1=NC(NC#N)=NC(NC#N)=N1 FJJCIZWZNKZHII-UHFFFAOYSA-N 0.000 description 1
- 229960005305 adenosine Drugs 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 238000004166 bioassay Methods 0.000 description 1
- 239000001511 capsicum annuum Substances 0.000 description 1
- 150000004657 carbamic acid derivatives Chemical class 0.000 description 1
- 108700021031 cdc Genes Proteins 0.000 description 1
- 230000030833 cell death Effects 0.000 description 1
- 230000032823 cell division Effects 0.000 description 1
- 235000019693 cherries Nutrition 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 230000008303 genetic mechanism Effects 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 108020004999 messenger RNA Proteins 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- CHNKRFXXARCZRN-UHFFFAOYSA-N n-benzyl-3-methyl-2h-pyrazolo[4,3-d]pyrimidin-7-amine Chemical compound N=1C=NC2=C(C)NN=C2C=1NCC1=CC=CC=C1 CHNKRFXXARCZRN-UHFFFAOYSA-N 0.000 description 1
- RAIFTQUCWIEUSY-UHFFFAOYSA-N n-cyclopentyl-2-methyl-7h-pyrrolo[2,3-d]pyrimidin-4-amine Chemical compound C=12C=CNC2=NC(C)=NC=1NC1CCCC1 RAIFTQUCWIEUSY-UHFFFAOYSA-N 0.000 description 1
- 230000003076 paracrine Effects 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- 239000005648 plant growth regulator Substances 0.000 description 1
- 239000003375 plant hormone Substances 0.000 description 1
- CBIDRCWHNCKSTO-UHFFFAOYSA-N prenyl diphosphate Chemical compound CC(C)=CCO[P@](O)(=O)OP(O)(O)=O CBIDRCWHNCKSTO-UHFFFAOYSA-N 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 125000005412 pyrazyl group Chemical group 0.000 description 1
- 150000003230 pyrimidines Chemical class 0.000 description 1
- 108020003175 receptors Proteins 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 239000001384 succinic acid Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000035897 transcription Effects 0.000 description 1
- 238000013518 transcription Methods 0.000 description 1
- 238000011144 upstream manufacturing Methods 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8261—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield
- C12N15/8291—Hormone-influenced development
- C12N15/8295—Cytokinins
Definitions
- the present invention relates to a method for rooting plants which are protected against undesired vegetative propagation, in addition to a DNA construct and a transgenic plant which enable conditional inhibition of vegetative propagation.
- Improvement stations invest a great deal of money in making new plant varieties. This money is recovered by selling the developed plants. A major problem arises here however in that the new varieties are often propagated illegally via cuttings or via grafting. An estimated 25 to 35% of all sold carnations is thus vegetatively propagated illegally (i.e. without payment of royalties) .
- the present inventors have developed a technology for inhibiting root formation conditionally (under particular conditions) . This technique is described in the international application 099/06579, the content of which is incorporated herein by means of reference.
- the action mechanism associated with this technology is based on the following principles.
- the plant growth regulator auxin is involved in the induction of roots on a shoot (adventive root formation) and in side root formation (lateral root formation) .
- Auxin occurs in some plants in a degree sufficient to induce roots on cuttings and in the case of some other plants it has to be administered additionally via a cutting powder (or via a solution) .
- Antagonists for these auxin-induced processes are also present in the plant.
- These antagonists are signal molecules such as for instance cytokinins and ethylene. Cytokinins not only inhibit rooting but can also inhibit graft union and lateral root formation.
- cytokinins zeatin or benzylaminopurine administered for a short period of time (4 hours) is capable of completely blocking in vitro root induction with auxin.
- the gene that codes for a protein which can play a key role in the formation of cytokinin is the isopentenyl transferase gene (ipt gene) from A ⁇ robacterium tumefaciens.
- ipt gene isopentenyl transferase gene
- the conversion of 5'- adenosine monophosphate + isopentenyl pyrophosphate in the cytokinin isopentenyl adenine is catalysed by the enzyme isopentenyl transferase. This enzyme is present after transcription and translation of the ipt gene.
- Isopentenyl adenine is converted rapidly in the plant to the very active cytokinin zeatin.
- Cytokinin formed via the ipt gene has a paracrine effect (at the location of synthesis) , so that pleiotropic effects (undesired side effects) will be limited.
- genes with which rooting or graft union can be inhibited are genes which induce cell death at the location where and the moment at which rooting or graft union would normally speaking be desirable. Regulation of genes which control cell division (cyclins and cell cycle genes, actin genes, scarecrow genes etc.) and genes which are involved in induction, formation and development of adventive root formation can be used to inhibit root formation (for instance via inhibition of functional gene expression) . In addition, genes which play a part in auxin transport, such as the PIN genes, can be used to inhibit root formation and graft union. In addition to blocking adventive root formation, the above stated genes can also be used to stop root formation at the moment when the root primordium is being formed or has already been formed.
- cytokinins formed after expression of the ipt gene are poorly transported in the plant, pleiotropic effects are limited. Expression of the ipt gene in a wounded leaf also has few adverse effects, because cytokinin is naturally involved in the recovery from wounds .
- the above described system is in principle very useful in preventing undesired vegetative propagation of plants. However, it also prevents propagation when this is desired, such as by the developer or breeder of the plant itself or with the permission of the developer or breeder . It is therefore the object of the present invention to provide a method whereby, if so required or desired, the inhibition of the vegetative propagation can be discontinued.
- a method for enabling rooting or grafting of a plant which contains in its genome a gene which is placed under the regulation of an inducible promoter and which codes for a rooting-inhibiting product or a product leading to rooting inhibition, comprising of treating the plant prior to production of a cutting or graft or treating the cutting or graft after production of the cutting or graft with a stimulus which: a) discontinues the effect of the rooting- inhibiting gene; and/or b) results in expression of a second gene likewise present in the plant which is under the regulation of an inducible promoter and the expression product of which discontinues the effect of the rooting-inhibiting gene.
- a stimulus which: a) discontinues the effect of the rooting- inhibiting gene; and/or b) results in expression of a second gene likewise present in the plant which is under the regulation of an inducible promoter and the expression product of which discontinues the effect of the rooting-inhibiting gene.
- the stimulus usually a substance which causes rooting inhibition to be discontinued directly or indirectly (via induction of the second gene)
- the stimulus can be made available by the owner of the plant variety to those who are authorized for vegetative propagation of a plant which is patented or protected by plant breeders ' rights and provided with the rooting-inhibiting mechanism.
- the stimulus which discontinues the effect of the rooting-inhibiting gene can be chosen from substances which inhibit the biosynthesis of the rooting-inhibiting product and structural analogs of the rooting-inhibiting product .
- Particularly suitable rooting-inhibiting substances are the endogenous plant hormones cytokinins. These can be produced in a plant in which the rooting-inhibiting mechanism is active via expression of the ipt gene, the product of which plays a key part in the cytokinin biosynthesis .
- the stimulus in particular the substance, which inhibits the biosynthesis of the cytokinin is a substance which is a structural analog of a precursor of a cytokinin, such as the substrates of IPT from which isopentenyl adenine and subsequently, via other enzymes, zeatin is made. Examples are shown in Table 1A.
- CBP various 4-substituted 2-methylpyrrolo [2, 3-d]pyrimidines, including: 4-cyclobutylamino-2-methylpyrrolo [2, 3-d] pyrimidine (CBP)
- CBP 4-cyclobutylamino-2-methylpyrrolo [2, 3-d] pyrimidine
- the second gene can thus be a gene coding for the antisense version of the rooting-inhibiting gene.
- the messenger transcribed from the antisense version of the gene captures the mRNA of the sense version whereby no translation to protein takes place.
- the protein is the rooting inhibitor itself or is required in the biosynthesis thereof. Now the product is no longer formed, the rooting inhibition is discontinued.
- the second gene preferably codes for an antisense version of the ipt gene.
- the second gene can further be a gene which codes for a second sense version of the rooting-inhibiting gene. Co-suppression can hereby be effected.
- the second gene preferably codes for a sense version of the ipt gene .
- the second gene can also be one of the rolABC genes of Aqrobacterium rhizo enes. Expression of the rolABC genes makes the plant more insensitive to cytokinin.
- the first gene is under the regulation of an inducible promoter which is modified, for instance a wound-inducible promoter which regulates expression of the ipt gene. The modification ensures that a repressor can interact with the promoter.
- the second gene the expression of which is likewise inducible (for instance via a chemical substance or via another method) , codes for a repressor-protein which inhibits expression of the first gene.
- An example hereof is the GAL4 repressor system.
- the rooting-inhibiting gene is therefore preferably the ipt gene, which is under the regulation of for instance a modified wound- inducible promoter, wherein the modification is such that the repressor of the GAL4 regulation system can interact therewith.
- the second gene can further code for a degradation enzyme of the rooting-inhibiting gene product.
- the rooting-inhibiting gene product is preferably cytokinin and the second gene then codes for instance for cytokinin-oxidase .
- the second gene can be a mutated cytokinin receptor gene, whereby the cytokinin pathway cannot take place and the rooting becomes conditional.
- the expression of the second gene is inducible (for instance with a chemical compound) and can therefore be switched on at the moment rooting is required by administering the inducer. Induction proceeds via the promoter.
- Examples hereof are gene-regulation systems which make use of promoters which are inducible with for instance ethanol, copper ions (or other metals) , tetracycline, dexamenthasone (and other glucocorticoid promoters) , benzothiadiazole, N- (aminocarbonyl) -2-chlorobenzene sulfonamide or tebufenozide .
- the invention further relates to a transgenic plant which is reversibly protected against undesired vegetative propagation, which plant contains in its genome a first gene which is placed under the regulation of an inducible first promoter and which codes for a rooting-inhibiting product or a product leading to rooting inhibition, and a second gene which is placed under the regulation of a second promoter inducible by means of another stimulus and which codes for a product which deactivates the rooting-inhibiting expression product of the first gene.
- the invention further relates to a DNA construct comprising transcription-initiation sequences, including an inducible promoter, and optionally transcription termination sequences operably linked to a second gene as defined above.
- the same DNA construct can advantageously further contain a first gene which codes for a rooting- inhibiting product or a product leading to rooting inhibition provided with transcription-initiation sequences operably linked thereto, including an inducible promoter, and optionally transcription termination sequences.
- the first gene is advantageously the ipt gene .
- the second gene can in both the transgenic plant and the DNA construct be everything as defined above.
- the invention further relates to a method for reversing rooting inhibition in a cutting or the growing together of a rootstock and upper stem (graft union) of a transgenic plant as described above, comprising of treating the cutting or graft with the stimulus of the second promoter and placing the cutting or graft on a rooting medium.
- a stimulus usually a substance
- this advantageously forms part of a composition, such as for instance a cutting powder or a graft promoter (substance which enhances the growing together of the graft with the lower stem) or a solution. Rooting or graft union is then only possible in the presence of this cutting powder, the graft promoter or a solution thereof.
- the cutting powder or graft promoter (or solutions thereof) can be administered after making the cutting or graft.
- the plants from which the graft or cutting is made can also be treated beforehand with the substance for inhibiting the effect of the ipt gene.
- the substances which discontinue the rooting inhibition directly, i.e. not via the genetic route, are mentioned above.
- other cytokinin inhibitors can be readily found among the arsenal of available substances. Finding these other substances can be done by testing a large number of substances in so-called high throughput screening (HTS) systems. Many thousands of compounds can be tested in the HTS systems.
- the IPT protein or bacteria containing or producing the IPT-protein
- cytokinin precursors (5 ' -adenosine monophosphate and isopentenylpyrophosphate) and potential inhibitors for testing.
- IP isopentenyl adenine
- zeatin is formed.
- the effectiveness of the substances which inhibit IP or zeatin formation van be further optimized via so-called "combinatorial chemistry". All this may result in the identification of substances which are suitable for direct application to discontinue the ipt activity in the plant (conditional inhibition of rooting) .
- the action of the genetic mechanism whereby rooting inhibition is discontinued is based on expression induction.
- the second gene which discontinues the activity of the rooting-inhibiting product is switched on at the desired moment by induction via its promoter.
- Inducible promoters are for instance the per se known systems inducible using alcohol and tetracycline.
- Other examples of inducers are copper ions (or other metals), dierithasone (and other glucocorticoid promoters) benzothiadiazole, N- (aminocarbonyl) -2-chlorobenzene sulfonamide or tebufenozide .
- DNA constructs containing the rooting-inhibiting gene and/or the gene which leads to discontinuation of the rooting inhibition with a marker gene, such as GUS or GFP. It is then possible throughout the whole chain - from producer tot consumer - to perform a very rapid test for the presence of the reporter, such as by means of a GUS assay or using a fluorescence meter.
- the construct which is incorporated can be identified via a Southern blot or PCR reaction.
- rooting-inhibiting gene is understood to mean a gene which codes for a rooting-inhibiting product or product leading to rooting inhibition, or a gene which codes for a product which can prevent graft union or which results in prevention of graft union.
- the gene product of the rooting- inhibiting gene is referred to as "rooting-inhibiting gene product”.
- Dit product is itself not necessarily rooting-inhibiting, but in any case results in inhibition of rooting or prevention of graft union.
- ipt gene resulted in rolB-ipt SRI tobacco tissue in a very strong increase in the formation of axillary shoots (between ten and twenty relative to the control plants which formed no axillary shoots), which points to an increased cytokinin content via expression of the ipt gene.
- transgenic rolB-ipt tobacco shoots Twenty of these transgenic rolB-ipt tobacco shoots were incubated for three weeks on Murashige and Skoog medium with 2% sucrose and the auxins indol-3-butyric acid (IBA) or naphthalene acetic acid (NAA) .
- the auxins were present during the entire incubation period in the following concentrations: 0, 1, 3.2, 10 and 100 ⁇ M.
- As control the same incubations were performed with wild type SRI tobacco shoots.
- the transgenic tobacco plants formed no roots.
- the wild type control shoots formed roots at all auxin concentrations. Strong callus formation was observed at 100 ⁇ M auxin.
- the rolB-ipt SRI tobacco shoots were incubated with 10 ⁇ M IBA plus 10 or 100 ⁇ M of the anti-cytokinin 2- cyclobutylamino-4-ethylamino-6-chloro-l, 3, 5-triazine . These shoots (see figure) were able to form roots, in contrast to the shoots which were incubated without anti-cytokinin. This shows that the effect of expression of the ipt gene can be prevented by anti-cytokinins . Other anti-cytokinins are listed in Table IB.
- Anti-cytokinin activity can also be obtained via introduction of a gene construct which prevents the effect of expression of the ipt gene, as explained in the description introduction.
- the techniques used for the above stated experiments are described in the following references:
- MS medium Murashige T, Skoog F. 1962. A revised medium for rapid growth and bioassays with tobacco tissue cultures. Physioloqia Plantarum 15, 473-497.
Landscapes
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Plant Pathology (AREA)
- Microbiology (AREA)
- Endocrinology (AREA)
- Biophysics (AREA)
- Cell Biology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Physics & Mathematics (AREA)
- Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
Abstract
La présente invention concerne un procédé permettant d'enraciner ou de greffer une plante contenant dans son génome un gène, placé sous la régulation d'un promoteur inductible, codant pour un produit inhibant l'enracinement ou pour un produit conduisant à une inhibition de l'enracinement. Ce procédé consiste à traiter la plante, avant production d'une bouture ou d'une greffe, ou de traiter la bouture ou le greffage, après leur production, au moyen d'une substance qui, ou bien stoppe l'effet du gène inhibant l'enracinement, ou/et permet l'expression d'un second gène du même genre, présent dans la plante, se trouvant sous la régulation d'un promoteur inductible, et dont le produit d'expression stoppe l'effet du gène inhibiteur d'enracinement. l'invention concerne, en outre, une plante transgénique, pourvue d'un mécanisme d'inhibition d'enracinement et d'un mécanisme qui stoppe l'inhibition d'enracinement, ainsi qu'un ADN chimère destiné à réaliser l'arrêt de l'inhibition d'enracinement.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| NL1012917 | 1999-08-26 | ||
| NL1012917 | 1999-08-26 | ||
| PCT/NL2000/000597 WO2001018170A2 (fr) | 1999-08-26 | 2000-08-28 | Inhibition conditionnelle de multiplication vegetative |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| EP1206559A2 true EP1206559A2 (fr) | 2002-05-22 |
Family
ID=19769792
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP00961249A Withdrawn EP1206559A2 (fr) | 1999-08-26 | 2000-08-28 | Inhibition conditionnelle de multiplication vegetative |
Country Status (3)
| Country | Link |
|---|---|
| EP (1) | EP1206559A2 (fr) |
| AU (1) | AU7323000A (fr) |
| WO (1) | WO2001018170A2 (fr) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2001273454A1 (en) | 2000-07-13 | 2002-01-30 | Pioneer Hi-Bred International, Inc. | ZmaXIG1 polynucleotides and methods of use |
| DE60333546D1 (de) * | 2003-05-06 | 2010-09-09 | Univ Palackeho | PyrazoloÄ4,3-DÜpyrimidines, verfahren zur ihre herstellung und deren verwendung |
| EP1656378A4 (fr) * | 2003-08-15 | 2011-05-11 | Irm Llc | Composes et compositions inhibiteurs de l'activite du recepteur tyrosine kinase |
| WO2005118588A1 (fr) * | 2004-06-02 | 2005-12-15 | Takeda Pharmaceutical Company Limited | Composé heterocyclique fusionné |
| EP1792630A1 (fr) * | 2005-12-02 | 2007-06-06 | The Procter & Gamble Company | Conjugués d'acides aminés et de la vitamine B3 pour l'administration transcutanée de la vitamine B3 |
| CN107711499A (zh) * | 2017-10-23 | 2018-02-23 | 西北农林科技大学 | 一种不同时间点6‑ba处理抑制培苗不定根发生的方法 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3810286A1 (de) * | 1988-03-25 | 1989-10-12 | Max Planck Gesellschaft | Transgene pflanze mit modifizierter physiologie, morphologie und modifiziertem hormonmetabolismus, gewebekulturen dieser pflanze und verfahren zu ihrer herstellung |
| JP2000513937A (ja) * | 1996-06-28 | 2000-10-24 | ユニバーシティー オブ ブリストル | 植物におけるgタンパク質シグナル伝達 |
| US6229066B1 (en) * | 1997-07-30 | 2001-05-08 | The Curators Of The University Of Missouri | Cytokinin oxidase |
| IL134282A0 (en) * | 1997-07-30 | 2001-04-30 | Inst Voor Agrobiologisch En Bo | Inhibition of unwanted hormone action in plants |
-
2000
- 2000-08-28 EP EP00961249A patent/EP1206559A2/fr not_active Withdrawn
- 2000-08-28 AU AU73230/00A patent/AU7323000A/en not_active Abandoned
- 2000-08-28 WO PCT/NL2000/000597 patent/WO2001018170A2/fr not_active Ceased
Non-Patent Citations (1)
| Title |
|---|
| See references of WO0118170A3 * |
Also Published As
| Publication number | Publication date |
|---|---|
| AU7323000A (en) | 2001-04-10 |
| WO2001018170A2 (fr) | 2001-03-15 |
| WO2001018170A3 (fr) | 2001-09-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Wu et al. | The diverse roles of cytokinins in regulating leaf development | |
| Salam et al. | Sucrose promotes stem branching through cytokinin | |
| Mauriat et al. | Gibberellins inhibit adventitious rooting in hybrid aspen and Arabidopsis by affecting auxin transport | |
| Gómez et al. | AtTPS1‐mediated trehalose 6‐phosphate synthesis is essential for embryogenic and vegetative growth and responsiveness to ABA in germinating seeds and stomatal guard cells | |
| Dawood et al. | A co-opted hormonal cascade activates dormant adventitious root primordia upon flooding in Solanum dulcamara | |
| Kolachevskaya et al. | Auxins in potato: molecular aspects and emerging roles in tuber formation and stress resistance | |
| Zhou et al. | Production and metabolic engineering of terpenoid indole alkaloids in cell cultures of the medicinal plant Catharanthus roseus (L.) G. Don (Madagascar periwinkle) | |
| Dayan et al. | Enhancing plant growth and fiber production by silencing GA 2‐oxidase | |
| Weise et al. | Engineering starch accumulation by manipulation of phosphate metabolism of starch | |
| Sonnewald et al. | Regulation of potato tuber sprouting | |
| Wightman et al. | Hormonal factors controlling the initiation and development of lateral roots: II. Effects of exogenous growth factors on lateral root formation in pea roots | |
| Savidge | Intrinsic regulation of cambial growth. | |
| Hartmann et al. | Reactivation of meristem activity and sprout growth in potato tubers require both cytokinin and gibberellin | |
| Durand et al. | The effect of marine bioactive substances (N PRO) and exogenous cytokinins on nitrate reductase activity in Arabidopsis thaliana | |
| Davies Jr et al. | The physiological basis of adventitious root formation | |
| Pasare et al. | The role of the potato (S olanum tuberosum) CCD8 gene in stolon and tuber development | |
| Schofield et al. | Over‐expression of STP13, a hexose transporter, improves plant growth and nitrogen use in Arabidopsis thaliana seedlings | |
| Pien et al. | Novel marker genes for early leaf development indicate spatial regulation of carbohydrate metabolism within the apical meristem | |
| Tréhin et al. | Cell cycle regulation by plant growth regulators: involvement of auxin and cytokinin in the re-entry of Petunia protoplasts into the cell cycle | |
| Aloni | Phytohormonal mechanisms that control wood quality formation in young and mature trees | |
| Kathiresan et al. | γ–aminobutyric acid promotes stem elongation in Stellaria longipes: The role of ethylene | |
| Aksenova et al. | Hormonal regulation of tuber formation in potato | |
| Song et al. | Far‐red light inhibits lateral bud growth mainly through enhancing apical dominance independently of strigolactone synthesis in tomato | |
| Si et al. | Influence of two nitrogen forms on hormone metabolism in potential storage roots and storage root number of sweetpotato | |
| Hu et al. | Modulation of SAMDC expression in Arabidopsis thaliana alters in vitro shoot organogenesis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
| 17P | Request for examination filed |
Effective date: 20020215 |
|
| AX | Request for extension of the european patent |
Free format text: AL;LT;LV;MK;RO;SI |
|
| RIN1 | Information on inventor provided before grant (corrected) |
Inventor name: KODDE, JAN Inventor name: VAN DER KRIEKEN, WILHELMUS, MARIA Inventor name: VAN LOOKEREN CAMPAGNE, MICHIEL, MAURITS |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
| 18D | Application deemed to be withdrawn |
Effective date: 20040302 |